Dr. Kilambi Pundarikakshudu
Ø Dr. Kilambi Pundarikakshudu (2019):- Anti-inflammatory and Anti-arthritic Activities of Some Food and Spices. In Bioactive Food as Dietary Interventions for Arthritis. Chapter 4. Eds. Ronald R. Watson and Victor R. Proody. (Pub: ELSEVIER).
Ø Dr. Kilambi Pundarikakshudu and Niranjan S. Kanaki (2019):- Analysis and Regulation of Traditional Indian Medicines (TIM). Special Guest Editor, Journal of A.O.A.C. International, Vol.102 (Thomson Reuters Impact factor:1.12)
Ø Anil Kumar Sharma and Dr. Kilambi Pundarikakshudu (2019):- Regulatory Aspects of Traditional Indian Medicines (TIM) in India and in International Purview. Journal of A.O.A.C. International, 102 (Thomson Reuters Impact factor: 1.12)
Ø Dr. Kilambi Pundarikakshudu, Anil Kumar Sharma, Chaitanya Bhatt and Niranajn S. Kanaki (2019):- Development and Validation of a High-Performance Thin Layer Chromatographic (HPTLC) Method for Simultaneous Quantification of Resorpino, Atropine and Piperino in Sarpagandha Ghanvari, Classical Ayurvedic Preparation. Journal of A.O.A.C. International, 102 (Thomson Routers Impact factor:1.12)
Ø Ghanshyam Parmar, Dr. Kilambi Pundarikakshudu, R. Balaraman, Girish Sailor (2018):- Analaphylactic and anti-asthmatic activity of Euphorbia thymifolia on experimental animals. Journal of Traditional and Complementary Medicine xxx (2018)1-6 (Pub: ELSEVIER)
Ø Ghanshyam Parmar, Dr. Kilambi Pundarikakshudu, R. Balaraman, Girish Sailor (2018):-Amelioration of anaphylaxis, mast cell degranulation and bronchospasm by Euphorbia hitra L. extracts in experimental animals. Beni-Suef University Journal of Basic and Applied Science 7 :127-134(Pub: ELSEVIER)
Dr. Shreeraj Shah
(Principal, LJIP; Prof. & HoD, Dept. Pharmaceutical Technology)
Ø Patent has been filed for (granting of patent) “Blood group Identification Development System (BIDS)” as one of the innovators, the project which is supported by SSIP, Gujarat and incubated at LJK Antrapreneur – The Business Incubator.
Ø He was nominated as Independent Director and partner of the start-up company named “REMEDIOS DE HIERBAS HERBALIVE AYURVEDIC HEALTH CARE LLP”. The company has trademarked brand ‘HerbALivE’.
Ø He was nominated as one of the resource persons by Federation of Indian Chambers of Commerce & Industry (FICCI) and Indian Drug Manufacturers Association (IDMA) for academia in Gujarat for 5th International Conference and Exhibition of Pharmaceuticals and Medical Devices – 2020, inaugurated by honorable Chief Minister Shri Vijay Rupani and Ministers of Central Government.
Ms. Palmi Modi
(Asst. Prof, Dept. of Pharmaceutical Chemistry)
Ø Ms. Palmi Modi, Shivani Patel, Mahosh Chhabria (2019):-Structure Based Design, Synthesis & Biological Evaluation of a Newer Series of Pyrazolo (1,5-a) Pyrimidinc analogues as potential anti-tubercular agents. Bioorganic Chemistry, 87, 240-251 (Thomson Reuters Impact factor: 3.929)
Dr. Sneha Sagar
(Asso. Prof., Dept. of Pharmaceutical Chemistry)
Ø Pharmacological investigation of Quinoxaline - Bisthiazoles as multi target –directed ligands for the treatment of Alzheimer's disease. Bioorganic Chemistry, Volume 89, August 2019 (Pub: ELSEVIER) (Thomson Reuters Impact Factor –3.926)
Ms. Tosha Pandya
(Asst. Prof., Dept. of Pharmaceutical Technology)
Ø Development and validation
of HPLC method for simultaneous estimation of Rifampicin & Ofloxacin using
experimental design. (Pub: Taylor & Francis) (Thomson Reuters Impact Factor